Anzahl der Einträge: 4.
Artikel
Silvestri, Guido,
Lévy, Yves ,
Lacabaratz, Christine,
Ellefsen-Lavoie, Kim,
Stöhr, Wolfgang,
Lelièvre, Jean-Daniel,
Bart, Pierre-Alexandre,
Launay, Odile,
Weber, Jonathan,
Salzberger, Bernd,
Wiedemann, Aurélie,
Surenaud, Mathieu,
Koelle, David M.,
Wolf, Hans,
Wagner, Ralf,
Rieux, Véronique,
Montefiori, David C.,
Yates, Nicole L.,
Tomaras, Georgia D.,
Gottardo, Raphael,
Mayer, Bryan,
Ding, Song,
Thiébaut, Rodolphe,
McCormack, Sheena,
Chêne, Geneviève und
Pantaleo, Giuseppe
(2020)
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial.
PLOS Pathogens 16 (6), e1008522.
Volltext nicht vorhanden.
Asbach, Benedikt,
Kibler, Karen V.,
Köstler, Josef,
Perdiguero, Beatriz,
Yates, Nicole L.,
Stanfield-Oakley, Sherry,
Tomaras, Georgia D.,
Kao, Shing-Fen,
Foulds, Kathryn E.,
Roederer, Mario,
Seaman, Michael S.,
Montefiori, David C.,
Parks, Robert,
Ferrari, Guido ,
Forthal, Donald N.,
Phogat, Sanjay,
Tartaglia, James,
Barnett, Susan W.,
Self, Steven G.,
Gottardo, Raphael,
Cristillo, Anthony D.,
Weiss, Deborah E.,
Galmin, Lindsey,
Ding, Song,
Heeney, Jonathan L. ,
Esteban, Mariano,
Jacobs, Bertram L.,
Pantaleo, Giuseppe,
Wagner, Ralf und
Silvestri, Guido
(2019)
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
Journal of Virology 93 (3).
Volltext nicht vorhanden.
Kibler, Karen V.,
Asbach, Benedikt,
Perdiguero, Beatriz,
García-Arriaza, Juan,
Yates, Nicole L.,
Parks, Robert,
Stanfield-Oakley, Sherry,
Ferrari, Guido ,
Montefiori, David C.,
Tomaras, Georgia D.,
Roederer, Mario,
Foulds, Kathryn E.,
Forthal, Donald N.,
Seaman, Michael S.,
Self, Steve,
Gottardo, Raphael,
Phogat, Sanjay,
Tartaglia, James,
Barnett, Susan,
Cristillo, Anthony D.,
Weiss, Deborah,
Galmin, Lindsey,
Ding, Song,
Heeney, Jonathan L. ,
Esteban, Mariano,
Wagner, Ralf,
Pantaleo, Giuseppe,
Jacobs, Bertram L. und
Silvestri, Guido
(2019)
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
Journal of Virology 93 (3).
Volltext nicht vorhanden.
García-Arriaza, Juan,
Perdiguero, Beatriz ,
Heeney, Jonathan L.,
Seaman, Michael S.,
Montefiori, David C.,
Yates, Nicole L.,
Tomaras, Georgia D.,
Ferrari, Guido ,
Foulds, Kathryn E.,
Roederer, Mario,
Self, Steven G.,
Borate, Bhavesh,
Gottardo, Raphael,
Phogat, Sanjay,
Tartaglia, Jim,
Barnett, Susan W.,
Burke, Brian,
Cristillo, Anthony D.,
Weiss, Deborah E.,
Lee, Carter,
Kibler, Karen V.,
Jacobs, Bertram L.,
Wagner, Ralf,
Ding, Song,
Pantaleo, Giuseppe,
Esteban, Mariano und
Silvestri, Guido
(2017)
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
Journal of Virology 91 (9).
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Wed Apr 24 13:39:46 2024 CEST.